Boone Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-398,065
Closed -$34.5M 19
2026
Q1
$34.5M Sell
398,065
-30,724
-7% -$2.94M 10.57% 4
2025
Q4
$41.2M Hold
428,789
12.93% 1
2025
Q3
$40.8M Hold
428,789
13.39% 1
2025
Q2
$37.4M Buy
428,789
+35,052
+9% +$2.97M 16.03% 1
2025
Q1
$35.4M Buy
+393,737
New +$35.2M 12.04% 2

Other funds holding MDT

Boone Capital Management's MDT Position: Q2 2026 in Review

Boone Capital Management sold out of Medtronic (MDT) in Q2 2026, closing a stake of 398,065 shares — an estimated $34.5M sold.

Boone Capital Management first reported a position in MDT in Q1 2025 and held it in 5 quarters. The position peaked at $41.2M in Q4 2025. 2,138 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Boone Capital Management reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Boone Capital Management sold 398,065 Medtronic shares in Q2 2026, an estimated $34.5M.
  • Boone Capital Management first reported a position in Medtronic in Q1 2025 and held it in 5 quarters.
  • Boone Capital Management's Medtronic position peaked at $41.2M in Q4 2025.
  • 2,138 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Boone Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.